sur Payments Group Holding (ETR:DE000A1M)
PGH Explores AI and Biotech for New Investment Opportunities
The Payments Group Holding (PGH), based in Frankfurt, has announced the identification of promising business activity fields and investment opportunities in artificial intelligence (AI) and the biotech sector. The company is pursuing ventures in AI company building, in collaboration with Softmax AI, and the development of a new radiopharmaceutical for diagnostic purposes.
A standout spin-off, Cognicare AI, caters to the growing elderly care sector, showcasing proven applications. PGH aims to capitalize on these opportunities to re-establish its position as a successful venture capital investor.
The pursuits in AI and biotech are considered additional diversification options alongside the planned acquisition of The Payments Group (TPG). If the TPG transaction terms are not favorable, PGH has positioned itself with promising alternatives to benefit from in 2026.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Payments Group Holding